logo-loader

Cereno Scientific AB

Market:
Unlisted (US)
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

Cereno Scientific is developing a new preventive drug that normalizes the body’s own defence system against blood clots – to be used on the global market for the treatment of complications resulting from thrombosis-related cardiovascular diseases.